$7.96
-0.05-0.62%
Last update: 11:36 AM
15 minutes delayed
Comments
Loading...
Theravance Biopharma (NASDAQ:TBPH) Stock, Earnings Estimates, EPS, And Revenue
Theravance Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 5
EPS Estimate
$-0.230
Quarterly Revenue Estimate
$15.3M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$62M
Analyze the earnings history of Theravance Biopharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Theravance Biopharma (TBPH) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-05 | $-0.13 | $-0.21 | 38.1 % |
| Mar 2024 | 2024-05-13 | $-0.09 | $-0.25 | 64.0 % |
| Dec 2023 | 2024-02-26 | $-0.17 | $-0.15 | -13.3 % |
| Sep 2023 | 2023-11-07 | $-0.17 | $-0.21 | 19.1 % |
Theravance Biopharma (TBPH) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-05 | $14.26M | $15.45M | -7.73 % |
| Mar 2024 | 2024-05-13 | $14.50M | $13.96M | 3.89 % |
| Dec 2023 | 2024-02-26 | $17.57M | $17.68M | -0.65 % |
| Sep 2023 | 2023-11-07 | $15.69M | $15.00M | 4.62 % |
FAQ
When is Theravance Biopharma (NASDAQ:TBPH) reporting earnings?
Theravance Biopharma (TBPH) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 5, 2024 for Q2.
What were the latest earnings per share (EPS) for Theravance Biopharma (NASDAQ:TBPH)?
The Actual EPS was $-0.13, which beat the estimate of $-0.21.
What were Theravance Biopharma’s (NASDAQ:TBPH) revenues?
The Actual Revenue was $14.3M, which missed the estimate of $15.4M.
Browse earnings estimates, EPS, and revenue on all stocks.